Private equity-based dermatology practice consolidation increased at a mean rate of 65% each year from 2012 to 2017, according to researchers from Brigham and Women’s Hospital and Harvard Medical School, in the current top story from August.
Large group practices may be able to negotiate more favorable reimbursement contracts with payers, but the effect of consolidation on clinical outcomes and health care expenditures has not been explored.
Keep scrolling to read additional hot topics this month determined by Healio Dermatology readers.
Private equity-backed groups acquiring more dermatology practices
The researchers noted a regional focus, with 36% of the acquired practices in Florida and Texas; acquisitions occurred in 30 states. Read more.
FDA accepts NDA for tazarotene lotion for acne
The FDA has accepted a new drug application for IDP-123, a lotion for the treatment of acne, according to an announcement from Bausch Health and Ortho Dermatologics, Bausch’s dermatology business. Read more.
Aerosol sunscreen application density higher than lotion in practical use
“Based on our results, spray sunscreen may provide higher but still inadequate levels of UV protection than other sunscreen vehicles but with a considerable amount of waste,” Lindsey Broussard, MD, of the department of dermatology at the University of Colorado Anschutz Medical Campus, told Healio Dermatology. Read more.
Two topical psoriasis treatments now indicated in patients 12 years and older
The FDA has expanded the indicated patient population for Enstilar foam for topical treatment of plaque psoriasis to include patients aged 12 years and older, according to a press release from Leo Pharma. Read more.
AAD: More education needed around dangers of UV exposure
The rates of melanoma, the deadliest form of skin cancer, are increasing exponentially, with research presented at the American Academy of Dermatology Summer Meeting reporting an 800% increase between 1970 and 2009 among women aged 18 to 39 years. Read more.